Title | Ruthenium(II) acetylacetonato-sulfoxide complexes |
Publication Type | Journal Article |
Year of Publication | 2003 |
Authors | Wu, A, Kennedy, DC, Patrick, BO, James, BR |
Journal | Inorganic Chemistry Communications |
Volume | 6 |
Pagination | 996-1000 |
Date Published | Aug |
Type of Article | Article |
ISBN Number | 1387-7003 |
Keywords | 2D NMR spectroscopy, acetylacetonato, ANTITUMOR-ACTIVITY, CANCER, CHEMISTRY, COLORIMETRIC ASSAY, COORDINATION, INVITRO, PRECURSOR, ruthenium, STRUCTURAL-CHARACTERIZATION, sulfoxides, TUMOR CELL-LINES |
Abstract | The water-soluble Ru-II acetylacetonato-sulfoxide complexes, cis-Ru(acac)(2)(DMSO)(2) (1) and Ru(acac)(2)(meso-BESE) (2), were synthesized (BESE = 1,2-bis(ethylsulfinyl)ethane = EtS(O)(CH2)(2)S(O)Et). Both complexes were characterized by H-1 and C-13{H-1} NMR, UV-Vis, and IR spectroscopies, as well as MS, elemental analysis, solution conductivity, and cyclic voltammetry, while the molecular structure of 2 was determined also by X-ray crystallography. All sulfoxide ligands are S-bonded. The complexes were tested against human breast cancer cells (MDA-MB-435S) using an in vitro MTT assay, a colorimetric determination of cell viability; IC50 values of >2000 and 1500 +/- 100 muM were determined for 1 and 2, respectively, while cisplatin exhibits an IC50 value of 30 +/- 5 muM. (C) 2003 Elsevier Science B.V. All rights reserved. |
URL | <Go to ISI>://000184518100004 |
